Sign in to continue:

Friday, April 17th, 2026

Pacific Radiance Ltd. Announces Material Variances Between FY2025 Unaudited and Audited Financial Statements; No Dividend Details Provided

PACIFIC RADIANCE LTD. FY2025: Analysis of Material Variances Between Unaudited and Audited Financial Statements

Pacific Radiance Ltd. has released details of material variances between its unaudited and audited financial statements for the financial year ended 31 December 2025. The adjustments, primarily related to the reclassification and write-back of investment in associates, have led to significant changes in several key financial metrics. Below, we provide a structured analysis of these changes, their implications, and recommendations for investors.

Key Financial Metrics and Variances

Metric Audited FY2025 Unaudited FY2025 Difference % Change
Investment in Associates (US\$’000) 11,733 8,846 +2,887 +33%
Accumulated Losses (US\$’000) (102,209) (105,124) +2,915 -3%
Other Operating Income (US\$’000) 8,755 3,368 +5,387 +160%
Share of Results of Associates & JVs (US\$’000) 710 3,182 -2,472 -78%
Profit for the Year (US\$’000) 15,801 12,886 +2,915 +23%
Write-back of Investment in Associates (US\$’000) 5,386 0 +5,386 +100%

Analysis of Financial Variances

  • Impairment Write-back: The most significant change was an additional impairment write-back of US\$2.89 million, driven by improved financial performance of an associate. This resulted in both higher investment in associates and a reduction in accumulated losses.
  • Reclassification of Income: The company reclassified certain income from ‘Share of Results of Associates’ to ‘Other Operating Income’, reflecting the impairment write-back more accurately. This led to a sharp rise in operating income and a corresponding decrease in the share of results from associates.
  • Profit Increase: Net profit for the year rose by 23% compared to the unaudited figures, largely due to the impairment write-back.

Exceptional Earnings

The company’s exceptional earnings during FY2025 are primarily attributed to the impairment write-back resulting from improved performance of an associate. This is a non-recurring event, and its impact is reflected both in the Statement of Profit and Loss and in the Statement of Cash Flows.

Statement from the Executive Chairman

No detailed Chairman’s statement was included in the notice; however, the announcement was signed by Pang Yoke Min, Executive Chairman, indicating the company’s proactive approach in clarifying financial adjustments. The tone of the announcement is factual and neutral, focusing on transparency regarding audit adjustments.

Errors or Inconsistencies in the Financials

The material variances between unaudited and audited accounts were primarily due to an additional impairment write-back and reclassification between income line items. There is no indication of fundamental errors or misstatements, but rather a refinement of accounting treatment after audit finalization.

Dividends, Share Buybacks, and Corporate Actions

No information regarding dividends, share buybacks, placements, or other corporate actions is disclosed in this notice. Investors should await further disclosures or the full annual report for details on these topics.

Outlook and Conclusion

The overall financial performance for FY2025 appears neutral to slightly positive, underpinned by a non-recurring impairment write-back. The improvement in an associate’s performance is a positive sign, but the uplift in earnings is not based on core operational growth. There are no clear forward-looking statements or guidance in this release.

Investor Recommendations

  • If you currently hold this stock: Maintain your position, but exercise caution. The profit boost is from a one-off item, not from recurring operations. Monitor subsequent disclosures and the company’s core operating performance closely.
  • If you do not currently hold this stock: Consider waiting for further information. The current uplift is non-recurring, and there’s no evidence of sustained operational improvement. Assess future results for signs of core earnings growth before taking a position.

Disclaimer: This analysis is based strictly on the disclosed financial variances and does not constitute investment advice. Please consult your financial advisor and review full company disclosures before making investment decisions.

View Pacific RadianceW270919 Historical chart here



BH Global Corporation Limited FY2025 Results: Revenue and Profit Down, No Final Dividend Declared

BH Global Corporation Limited (SGX: BQN) FY2025 Financial Re...

Quantum Healthcare Limited FY2025 Financial Results: Revenue Growth, Losses Continue, No Dividend Declared

Quantum Healthcare Limited FY2025 Results: Financial Analysi...

   Ad